EUCANCan
A federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalised Medicine
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 825835.
€ 6.527.563,75
01/01/2019 – 31/12/2022 (4 years)
Barcelona Supercomputing Center
VIEW PARTNERS >
German Cancer Research Center
Ontario Institute for Cancer Research
Centre National De La Recherche Scientifique
Stichting Hartwig Medical Foundation
Fundacio Centre De Regulacio Genomica
European Molecular Biology Laboratory
Consorci Institut D’investigacions Biomediques August Pi I Sunyer
Institut Catala D’oncologia
Vall d’Hebron Institute of OncologyUniversitatsklinikum Heidelberg
Charite – Universitaetsmedizin Berlin
Institut Curie
Royal Institution for the Advancement of Learning Mcgill University
Universidad Del Pais Vasco/ Euskal Herriko Unibertsitatea
Heidelberger Akademie Der Wissenschaften
Linq Management
Steinbeis Transfer
Why it matters
EUCANCan aims at supporting and enhancing modern oncology, by implementing a cultural, technological and legal integrated framework across Europe and Canada, to enable and facilitate the efficient analysis, management and sharing of cancer genomic data.
This cooperative framework is not only expected to immediately contribute to improve biomedical research in cancer, but to also serve as a model for globalizing and enriching personalised medicine initiatives, allowing the exchange of data, clinical experience and information across different national health systems.
What ECPC does
ECPC Chair of Scientific Committee Francesco de Lorenzo sits on the EUCANCan Advisory Board to ensure the project activities are in line with the needs of cancer patients by actively participating in discussions and providing feedback and input on research activities and outputs.
This project is funded by the European Union.